[ad_1]
New Delhi, Delhi, India:
- The first international study confirms the ability of Plasmacluster ion technology to reduce the secretion of airway mucus, a problem for asthma patients.
- PCI technology also helps reduce the symptoms of asthma related to airway conditions such as asthma.
SHARP Business Systems (India) Pvt. Ltd, a wholly owned Indian subsidiary of SHARP Corporation Japan, known worldwide for its unique technological products and solutions, today announced the results of a new study that validates the technology’s anti-aging power Plasmacluster ion (PCI) is included in Sharp Air cleaning equipment for respiratory diseases. Like asthma – a leading cause of illness and death in India. The investigative study led by Dr. Munemasa Mori, an expert in respiratory medicine and stem cell research was conducted at the famous Columbia University Irving Medical Center, a famous research center in the United States.
The study was designed to investigate the effects of Plasmacluster ions on the airways and airway epithelial cells that line the airway from the nose to the lungs. This epithelial epithelium plays an important role in the secretion of mucus by expelling foreign substances in the mucus secretion from the secretory cells and uniting the motile ciliated cells. As part of the study, human tissue stem cells were first induced over a period of one month. The cultured cells formed a scaffold and were then exposed to Plasmacluster ions for 24 hours.
As part of a research study, researchers found a decrease in a marker associated with highly cloudy mucus associated with air pollution in the airways of asthmatics and an increase in a marker associated with it has a smooth secreted protein associated with low-viscosity mucus that helps to improve. breath These changes prevent symptoms by improving the flow of mucus in the airways, which is a major problem for people with asthma.
Speaking of development, Narita Osamu, Managing Director, SHARP Business Systems (India) Pvt. Ltd said, “Continuously rising pollution levels across India’s cities have raised new challenges, making it difficult to access clean and natural air. The situation is even more difficult for children, elderly people, and people with respiratory problems such as asthma, where the increase in pollution can affect their quality of life. Among the growing concerns, new research results that shows the positive effect of Plasmacluster ion technology in reducing the secretion of mucus in the airways, increasing the quality of life for asthma patients. remove toxic air pollutants from indoor air, and we continue to work with experts and industry to learn and improve the effectiveness of our products to ensure a clean and safe environment for all.
Dr. Munemasa Mori, Assistant Professor, Columbia University Department of Medicine said, “I was interested in how the Plasmacluster technology, with its great ability to reduce viruses, would affect the human respiratory system. So, my research team and I designed and conducted the experiment. We exposed Plasmacluster ions to different airway epithelial cells from human stem cells and observed changes in mucus markers. This is an important insight because the symptoms may arise asthma at the cellular level. We are excited to investigate and re-evaluate the effects of Plasmacluster ions on airway epithelial cells using patient-derived cells, the long-term effects, investigating the possible method, etc. I look forward to the technological advances of the Plasmacluster technology that can lead to their contribution to new medicines.
Since the introduction in 2000 of the first air purifiers equipped with Plasmacluster ion technology, Sharp’s air cleaning technology has proven effective against the new coronavirus (SARS-CoV-2), viruses, bacteria, mold and odors. Sharp has sold more than 100 million products across 23 categories, equipped with Plasmacluster ion technology, including air cleaners, air conditioners, refrigerators and other product categories. PCI technology has been tested and validated by more than 35 international scientific institutions including IIT Delhi.
Using Plasmacluster technology, negative hydrogen ions and positive hydrogen ions are released simultaneously, and the positive and negative ions directly bind to airborne germs, fungi, viruses, and allergens. By chemically degrading the proteins on the surface, this air filtration method reduces bacterial activity. More than 13 test facilities outside of Japan have tested the effectiveness of Plasmacluster technology in preventing the action of harmful substances such as airborne Serratia bacteria that are a source of diseases in received at the hospital (Dr. Melvin W. First, US), avian influenza viruses. (Institute Pasteur, Vietnam), and clinical effectiveness in reducing the incidence of tuberculosis in tuberculosis hospitals (National Center of Tuberculosis and Lung Diseases, Georgia).
Results of the Verification Test conducted by Columbia University, USA
During the experiment, no visible negative-morphological changes or damage of epithelial epithelial cells in human lungs were confirmed after exposure to Plasmacluster ions for 24 hours.
In addition to this,
- Decreased expression of MUC5AC, a protein marker associated with respiratory failure by increasing high-viscous mucus in the airways of asthmatic patients was confirmed after exposure to Plasmacluster ions.
- An increase in SCGB1A1, a protein marker associated with helping to improve breathing by increasing less-poky mucus was seen after exposure to Plasmacluster ions.
About Sharp Business Systems (India)
Sharp Business Systems (India) Pvt Ltd is an ISO 900l: 2015 Certified and wholly owned Indian subsidiary of Sharp Corporation, Japan a 110-year-old company with many technological achievements. Supported by a strong sales force and a trained service team, our business provides a number of market leading B2B and B2C products in a wide range of new office solutions, Visual Solutions and Real Estate Solutions across India for over 20 years.
[ad_2]
Source link
.jpg)
